Average cost of multi drug-resistant tuberculosis treatment in Angola
Angola: Average cost of multi drug-resistant tuberculosis treatment was 537 constant 2022 US$ in 2023. ▼ Falling
Latest (2023)
537 constant 2022 US$
Change on year
down 77.4%
World rank
76th
of 92 countries
All-time high
3,748 constant 2022 US$
in 2018
All-time low
537 constant 2022 US$
in 2023
Years of data
7
2017–2023
Average cost of multi drug-resistant tuberculosis treatment in Angola, 2017–2023
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
The most recent figure for average cost of multi drug-resistant tuberculosis treatment in Angola is 537 constant 2022 US$, measured in 2023. That is the lowest value across all 7 years on record.
That represents a change of down 77.4% on the previous year and down 63.7% over ten years.
Angola ranks 76th of 92 countries on this measure, in the bottom quarter.
Average cost of multi drug-resistant tuberculosis treatment in Angola, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 1,480 constant 2022 US$ | — |
| 2018 | 3,748 constant 2022 US$ | +153.2% |
| 2019 | 1,624 constant 2022 US$ | -56.7% |
| 2020 | 2,377 constant 2022 US$ | +46.4% |
| 2021 | 2,377 constant 2022 US$ | +0.0% |
| 2022 | 2,377 constant 2022 US$ | +0.0% |
| 2023 | 537 constant 2022 US$ | -77.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2,284 constant 2022 US$ | 1,480 constant 2022 US$ | 3,748 constant 2022 US$ | 3 |
| 2020s | 1,917 constant 2022 US$ | 537 constant 2022 US$ | 2,377 constant 2022 US$ | 4 |
Countries ranked near Angola
- 73 El Salvador 574 constant 2022 US$ compare
- 74 Panama 572 constant 2022 US$ compare
- 75 Peru 570 constant 2022 US$ compare
- 77 Madagascar 532 constant 2022 US$ compare
- 78 Cape Verde 500 constant 2022 US$ compare
- 78 Ghana 500 constant 2022 US$ compare
More health data for Angola
- Un projection of annual infant deaths, annual growth rate -1.27 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.05 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 740.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31,754 deaths (2100)
- Population ages 80 and above, female, per capita 0.0021 units per person (2025)
- Population ages 80 and above, male, annual growth rate 4.27 % change on previous year (2025)
- Population ages 80 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 80 and above, male, per capita 0.0013 units per person (2025)
- Pertussis - number of reported cases, gaps filled 1,150 (2025)
- Pertussis - number of reported cases, per capita 0 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Angola?
- Average cost of multi drug-resistant tuberculosis treatment in Angola was 537 constant 2022 US$ in 2023, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Angola?
- The highest recorded value was 3,748 constant 2022 US$ in 2018.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Angola?
- The lowest recorded value was 537 constant 2022 US$ in 2023.
- How does Angola rank for average cost of multi drug-resistant tuberculosis treatment?
- Angola ranks 76th out of 92 countries with data for 2023.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Angola?
- Over the last ten years it is down 63.7%. The long-run trend across the full record is falling.
- Where does this Angola data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.